Fig. 2From: Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomasASL-based blood flow is altered by mTMZ. a Spider plot of ASL blood flow in individual subjects. b Subject 5 had an initial increase in the normalized blood flow ratio from 0.70 at baseline to 0.92 at 6Â weeks, followed by a decrease to 0.51 at 12Â weeks and subsequently two successive increases to 0.72 and 1.53 at 18 and 24Â weeks, respectively, as a result of a new focus of tumor in the ipsilateral brain (arrowhead). c Subject 9 had a gradual and sustained decrease of more than 50% in the blood flow ratio over time, from 0.91 at baseline to 0.39 at 54Â weeksBack to article page